Literature DB >> 3790625

Abnormalities of one-carbon metabolism in psychiatric disorders: study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes.

J R Smythies, R D Alarcon, D Morere, J A Monti, M Steele, L C Tolbert, W G Walter-Ryan.   

Abstract

Two independent lines of inquiry have implicated some disturbance of one-carbon cycle metabolism in affective disorders. Folic acid deficiency commonly leads to depression, and S-adenosylmethionine has been reported to have antidepressant properties. Methionine adenosyltransferase has been reported to be underactive in depression and schizophrenia and overactive in mania. This study reports the effects on erythrocyte methionine adenosyltransferase (MAT) kinetics (Vmax) of a 2-week treatment in a population of patients housed on a psychiatric research ward. The drug-free schizophrenic patients and depressives had, upon admission, low Vmax values, and the drug-free manic patients had high Vmax values on admission. After 2 weeks of appropriate treatment, the values for all three patient samples showed significant normalization (i.e., the levels rose in schizophrenics and depressives and fell in manics). We have further shown that pretreatment low levels of erythrocyte membrane phosphatidylcholine in depressives and high levels in manics show statistically significant normalization following 2 weeks of pharmacotherapy. The significance of these results is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790625     DOI: 10.1016/0006-3223(86)90330-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  6 in total

1.  Homocysteinemia is a common feature of schizophrenia.

Authors:  B Regland; B V Johansson; B Grenfeldt; L T Hjelmgren; M Medhus
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  Folate nutrition and blood-brain barrier dysfunction.

Authors:  Patrick J Stover; Jane Durga; Martha S Field
Journal:  Curr Opin Biotechnol       Date:  2017-02-10       Impact factor: 9.740

3.  Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis.

Authors:  B Regland; T Germgård; C G Gottfries; B Grenfeldt; A C Koch-Schmidt
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Homocysteinemia and schizophrenia as a case of methylation deficiency.

Authors:  B Regland; B V Johansson; C G Gottfries
Journal:  J Neural Transm Gen Sect       Date:  1994

5.  Is L-methionine a trigger factor for Alzheimer's-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice.

Authors:  Cheril Tapia-Rojas; Carolina B Lindsay; Carla Montecinos-Oliva; Macarena S Arrazola; Rocio M Retamales; Daniel Bunout; Sandra Hirsch; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2015-11-21       Impact factor: 14.195

6.  Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics.

Authors:  Y Ji; J M Biernacka; S Hebbring; Y Chai; G D Jenkins; A Batzler; K A Snyder; M S Drews; Z Desta; D Flockhart; T Mushiroda; M Kubo; Y Nakamura; N Kamatani; D Schaid; R M Weinshilboum; D A Mrazek
Journal:  Pharmacogenomics J       Date:  2012-08-21       Impact factor: 3.550

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.